TickerFacts.

Aspira Women's Health Inc. (AWHL): R&D Expense

Annual figures by period end, from SEC filings.

$2.88M
Year ended 2025-12-31
$3.12M
Trailing 12 months to 2026-06-30
-21.4%
3-year compound annual growth
+6.5%
5-year compound annual growth
-2.6%
10-year compound annual growth
$5.92M2010-12-31: $3.85M2011-12-31: $5.39M2012-12-31: $2.22M2013-12-31: $2.60M2014-12-31: $4.67M2015-12-31: $3.75M2016-12-31: $2.17M2017-12-31: $837.0K2018-12-31: $550.0K2019-12-31: $1.02M2020-12-31: $2.10M2021-12-31: $5.31M2022-12-31: $5.92M2023-12-31: $4.04M2024-12-31: $3.27M2025-12-31: $2.88M$2.88M
2010-12-31 R&D Expense (USD) 2025-12-31
Period endedR&D ExpenseChange YoYSource filing
2025-12-31$2.88M-11.9%2026-04-01, From 2025-01-01
2024-12-31$3.27M-19.1%2026-04-01, From 2024-01-01
2023-12-31$4.04M-31.8%2025-03-27, From 2023-01-01
2022-12-31$5.92M+11.3%2024-04-01, From 2022-01-01
2021-12-31$5.31M+152.6%2023-10-26, From 2021-01-01
2020-12-31$2.10M+106.7%2022-03-31, From 2020-01-01
2019-12-31$1.02M+85.1%2021-03-31, From 2019-01-01
2018-12-31$550.0K-34.3%2020-04-07, From 2018-01-01
2017-12-31$837.0K-61.5%2019-03-28, From 2017-01-01
2016-12-31$2.17M-42.1%2018-03-13, From 2016-01-01
2015-12-31$3.75M-19.6%2017-03-31, From 2015-01-01
2014-12-31$4.67M+79.8%2016-03-30, From 2014-01-01
2013-12-31$2.60M+17.1%2015-03-31, From 2013-01-01
2012-12-31$2.22M-58.9%2014-03-31, From 2012-01-01
2011-12-31$5.39M+40.0%2013-03-01, From 2011-01-01
2010-12-31$3.85Mn/a2012-03-27, From 2010-01-01

R&D Expense at similar companies

Companies with the same SEC industry code (In Vitro & In Vivo Diagnostic Substances), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedR&D ExpenseChange YoY
Aspira Women's Health Inc. (AWHL)2025-12-31$2.88M-11.9%
Anbio Biotechnology (NNNN)2025-12-31$201.3K-55.7%
Biomerica Inc (BMRA)2026-05-31$788.0K-23.0%
Insight Molecular Diagnostics Inc. (IMDX)2025-12-31$15.90M+61.6%
Immucell Corp (ICCC)2025-12-31$3.04M-22.0%
Alpha Teknova, Inc. (TKNO)2025-12-31$2.20M-20.4%
Volitionrx Ltd (VNRX)2025-12-31$10.08M-30.0%
Celldex Therapeutics, Inc. (CLDX)2025-12-31$245.07M+49.8%
Intellia Therapeutics, Inc. (NTLA)2025-12-31$388.86M-16.6%

Compare AWHL, NNNN, BMRA, IMDX side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗